"A more accurate mammogram: Genius™"*

SHERYL CROW
Breast Cancer Survivor

The more accurate Genius™ 3D™ exam is now more comfortable.

Enter your information and check the box below to receive a list of facilities near you that offer the Genius™ exam with the SmartCurve™ system.

HyperFocal: 0

Welcome to a more accurate and more comfortable mammogram.

Only the Genius™ 3D Mammography™ exam:

  • Is approved by the FDA as a superior mammogram for women with dense breasts.4-5*
  • Detects 20-65% more invasive breast cancers, compared to 2D mammography alone.6
  • With the SmartCurve™ system9, reduces the amount of discomfort you feel during your mammogram.10

 

Why is a Genius™ 3D Mammography™ exam with the SmartCurve™ system better?

  • Clinically proven to improve comfort in 93% of patients who reported moderate to severe discomfort with standard compression technology.10

  • 95% of patients would recommend a facility that offers the SmartCurve system.10

  • The only system featuring a curved design of the compression device — which mirrors the shape of a woman’s breast to reduce pinching and applies uniform compression over the entire breast for added comfort.10

Only available on the Dimensions® family of mammography systems.

Visit MyGenius3D.com

* Compared to 2D mammography alone.

  1. Breastcancer.org. US breast cancer statistics. Breastcancer.org. http://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed on: May 25, 2016

  2. Ho JM, Jafferjee N, Covarrubias GM, Ghesani M, Handler B. Dense breasts: a review of reporting legislation and available supplemental screening options. AJR Am J Roentgenol. 203(2):449-56, 2014.

  3. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 106(10), 2014.

  4. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005

  5. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.

  6. Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.

  7. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.

  8. National Breast Cancer Foundation, Inc. Stages 0 & 1: what does is mean to have stage 1 breast cancer? National Breast Cancer Foundation, Inc. http://www.nationalbreastcancer.org/breast-cancer-stage-0- and-1. Accessed on: March 31, 2015

  9. Not available at all facilities. Please contact your healthcare professional for more information.

  10. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00019 Rev 003(2017)